Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma

Although chemotherapy remains among the best treatment options for most cancers, adjuvant therapies such as dendritic cell (DC)-based immunotherapy have been added to treatment protocols to destroy residual tumour cells. Combination treatment with low-dose temozolomide (TMZ) chemotherapy followed by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Chang-Hyun, Woo, Sun-Je, Park, Jung-Sun, Kim, Hye-Sung, Park, Mi-Young, Park, Sung-Dong, Hong, Yong-Kil, Kim, Tai-Gyu
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2007
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2266048/
https://ncbi.nlm.nih.gov/pubmed/17645496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2567.2007.02680.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados